Clinical Trials Sponsored by Unither Pharmaceuticals, France

Total 122 results

Unither Pharmaceuticals, France

Completed

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study (NIAGARA)

Head and Neck Cancer | Xerostomia | Hyposalivation | Sjögren Syndrome

France
Unither Pharmaceuticals, France
International Pharmaceutical Research Center

Completed

Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution)

Healthy

Jordan
Unither Pharmaceuticals, France
AIXIAL Development

Completed

Paracetamol UNIFLASH for Buccal Use Phase III Trial in Acute Pain Due to a Tooth Extraction

Acute Pain

Spain, France, Italy, Poland
Unither Pharmaceuticals, France
Raptim Research

Completed

Pharmacokinetic Study of Paracetamol UNIFLASH (125 MG/1.25 ML)

Acute Pain

India
Unither Pharmaceuticals, France
EXCELYA Bordeaux

Completed

Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction

Acute Pain

France, Russian Federation, Belgium, Hungary, United Kingdom
United Therapeutics

Unknown

12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.

Hepatitis C

United States
Unither Pharmaceuticals

Terminated

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Ovarian Cancer
Unither Pharmaceuticals

Terminated

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Ovarian Neoplasms

Canada, United States
Unither Pharmaceuticals

Terminated

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

Ovarian Neoplasms

United States
Unither Pharmaceuticals

Terminated

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer

United States
Unither Pharmaceuticals, France
Accutest Research Laboratories (I) Pvt. Ltd.

Completed

Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg) (ARL/20/277)

Healthy Volunteers

India
United Pharmaceuticals

Completed

Efficacy of a New Thickened Extensively Hydrolyzed Formula (ALLAR)

Protein Allergy | Cow's Milk Protein Hypersensitivity

Slovenia, Belgium, Greece, Kuwait, Lebanon
United Pharmaceuticals

Completed

A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates

Cow Milk Allergy

France
United Pharmaceuticals

Completed

Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy (Paradice)

Milk Hypersensitivity | Food Sensitivity | Protein Allergy

Belgium
United Pharmaceuticals

Completed

Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula (SONAR)

Gastroesophageal Reflux

Belgium, France
United Pharmaceuticals

Active, not recruiting

Evaluation of an Adapted Formula on Atopic Dermatitis.

Atopic Dermatitis

Belgium, France
United Pharmaceuticals

Completed

Evaluation of the Hypoallergenicity of an Extensively Hydrolyzed Formula (ALYCE)

Cow Milk Allergy

Italy
United Pharmaceuticals

Completed

SWAN: Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01) (SWAN)

Gastroesophageal Reflux

Belgium
United Pharmaceuticals

Completed

Cow Milk Allergy: Evaluation of the Efficacy of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow Milk Allergy (COMETE)

Cow Milk Allergy

Italy, France, Belgium
Nutrimemo Consortium
ITERG; Unither Pharmaceuticals, France; Laboratory of Nutrition And Integrative... and other collaborators

Unknown

Effect of Lipidic Nutrients on Memory and Well Being in Healthy Aging Adults (NUTRIMEMO)

Healthy

France
University Hospital, Clermont-Ferrand
Unither Pharmaceuticals

Completed

Pilot Study of Pharmacology of Paracetamol Administered Per-oral Mucosa (PMB)

Healthy
United Pharmaceuticals
Statitec

Completed

Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins

Cow Milk Allergy

Belgium, France, Italy
United Pharmaceuticals
Statitec

Unknown

Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR) (STELLAR)

Gastroesophageal Reflux in Children
United Pharmaceuticals
Delta Consultants

Recruiting

Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation

Functional Constipation

Italy
Global United Pharmaceutical Corporation

Not yet recruiting

Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults (CREWS01)

Asthma

United States
UNICANCER
Novartis; National Cancer Institute, France; Chugai Pharmaceutical; Ligue contre... and other collaborators

Active, not recruiting

Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma (OS2006)

Sarcoma

France
Centre Oscar Lambret
Novartis Pharmaceuticals; National Cancer Institute, France

Completed

Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma (MIITOP)

Neuroblastoma

France
Ariad Pharmaceuticals
United BioSource, LLC

Terminated

An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® (OMNI)

Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL

United States
Aurinia Pharmaceuticals Inc.
United BioSource, LLC

Recruiting

LUPKYNIS US Registry Trial

Lupus Nephritis

United States
Biogen
Elan Pharmaceuticals; United BioSource, LLC

Completed

JC-Virus (JCV) Antibody Program (STRATIFY-1)

Multiple Sclerosis

United States
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Active, not recruiting

Study Impact on Outcome of Eltrombopag in Elderly Patients With Acute Myeloid Leukemia Receiving Induction Chemotherapy (EPAG2015)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Terminated

The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line

Essential Thrombocythemia

France
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Completed

Phase I Study in RAD 001 Patients With Relapse AML

AML

France
Frankel, Amylynne, M.D.
Graceway Pharmaceuticals, LLC

Unknown

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

Actinic Keratosis

United States
OncBioMune Pharmaceuticals
United States Department of Defense

Unknown

Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients (PSA)

Prostate Cancer

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; Merz Pharmaceuticals

Recruiting

Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) (BOTAF)

Cardiac Surgery

France
Perha Pharmaceuticals
Fondation Jérôme Lejeune; European Innovation Council; France 2030 program

Recruiting

Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease (LEUCETTA)

Healthy Volunteers | Down Syndrome | Alzheimer's Disease

France
Assistance Publique - Hôpitaux de Paris
IPSEN pharmaceutical company, Boulogne-Billancourt, France

Completed

Lanreotide In Polycystic Kidney Disease Study (LIPS)

Autosomal Dominant Polycystic Kidney Disease (ADPKD

France
Armata Pharmaceuticals, Inc.
United States Department of Defense

Recruiting

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (diSArm)

Bacteremia | Staphylococcus Aureus | Staphylococcus Aureus Bacteremia | Bacteremia Due to Staphylococcus Aureus | Bacteremia Staph

United States, Australia
Institut National de la Recherche Agronomique
National Research Agency, France; Solvay Pharmaceuticals

Completed

Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis

Pancreatitis

France
Race Oncology Ltd
Astex Pharmaceuticals, Inc.

Withdrawn

A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS (BISECT)

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic Syndrome

Australia
Institut National de la Santé Et de la Recherche...
Aventis Pharmaceuticals

Unknown

Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment

Dementia | Alzheimer's Disease | Neurodegenerative Disorders

France
Children's Hospital of Orange County
Ultragenyx Pharmaceutical Inc

Recruiting

Cardiovascular Structure and Function in the Mucopolysaccharidoses

Inflammation | Mucopolysaccharidoses | Cardiac Disease | Carotid Disease

United States
National Taiwan Sport University
Prince Pharmaceutical Co., Ltd

Completed

Vitamin B Complex Improved Exercise Performance and Anti-fatigue

Fatigue | Exercise Performance

Taiwan
Dr. Grace Parraga
Novartis Pharmaceuticals

Withdrawn

Investigating the Effects of QVM149 on MRI Ventilation Defects (XPERTT)

Asthma

Canada
The University of Texas Medical Branch, Galveston
Novartis Pharmaceuticals

Terminated

Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations

Diabetes | Immunosuppression

United States
Montefiore Medical Center
United States Department of Defense; Jazz Pharmaceuticals

Recruiting

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

Autism Spectrum Disorder

United States
Nantes University Hospital
Chugai Pharmaceutical; French Innovative Leukemia Organisation

Completed

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk (LAM2006IR)

Acute Myeloid Leukemia

France
Institut National de la Santé Et de la Recherche...
Ultragenyx Pharmaceutical Inc

Completed

Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS (GLUT-HEP)

Glut1 Deficiency Syndrome

France
Institut National de la Santé Et de la Recherche...
Ultragenyx Pharmaceutical Inc

Completed

A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease (TRIHEP3)

Huntington Disease

France, Netherlands

Clinical Trials Sponsored by Unither Pharmaceuticals, France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations